Literature DB >> 29383470

Purification of virus-like particles (VLPs) expressed in the silkworm Bombyx mori.

Robert Minkner1, Enoch Y Park2.   

Abstract

Virus-like particles (VLPs) are a promising and developing option for vaccination and gene therapy. They are also interesting as shuttles for drug targeting. Currently, several different gene expression systems are available, among which the silkworm expression system is known for its mass production capacity. However, cost-effective purification with high purity of the target protein is a particular bottleneck for this system. The present review evaluates the advances in the purification of VLPs, especially from silkworm larval hemolymph. Beginning with applicable pre-treatments for VLPs over to chromatography methods and quality control of the purified VLPs. Whereupon the main focus is on the different chromatography approaches for the purification, but the structure of the VLPs and their intended use for humans make also the quality control important. Within this, the stability of the VLPs which has to be considered for the purification is as well discussed.

Entities:  

Keywords:  Chromatography; Hemolymph; Purification; Silkworm; Virus-like particle

Mesh:

Substances:

Year:  2018        PMID: 29383470     DOI: 10.1007/s10529-018-2516-5

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  4 in total

Review 1.  Mucosal vaccines and technology.

Authors:  A Miquel-Clopés; E G Bentley; J P Stewart; S R Carding
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

2.  Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.

Authors:  Tatsuya Kato; Yoshihiro Takami; Vipin Kumar Deo; Enoch Y Park
Journal:  J Biotechnol       Date:  2019-10-12       Impact factor: 3.307

3.  Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate.

Authors:  Tatsuya Kato; Tatsuki Kakuta; Ami Yonezuka; Tomofumi Sekiguchi; Yuki Machida; Jian Xu; Tohru Suzuki; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2022-08-13       Impact factor: 2.860

Review 4.  Development of virus-like particles-based vaccines against coronaviruses.

Authors:  Chean Yeah Yong; Winnie Pui Pui Liew; Hui Kian Ong; Chit Laa Poh
Journal:  Biotechnol Prog       Date:  2022-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.